A new study has found that a combination of two drugs could enhance the immune system to treat one of the most common types of cancer in the world, bowel cancer. Also known as colorectal cancer, despite its widespread presence, the treatment options for this condition are limited. What the study specifically found was that this procedure could shrink the tumours caused by this condition by around 60%.

What Are The Drugs Involved

The trial involved the use of two immunotherapy drugs, botancilimab and balstilumab. It is a monoclonal antibody that works to stimulate the body's immune system to attack cancer. The study is a rather significant find, as it’s the first time that a consistent and durable response to immunotherapy has been reported in patients with solid MSS mCRC tumours.

The study was divided into several phases for more than 6 months. In the US trial, around around 101 patients with microsatile stable metastatic colorectal (MSS-mCRC) tumours showed a decrease . Around 61% of the patients experienced tumour shrinkage or stabilization after combined treatment with votancilumab and balstilumab. When it comes to downsides, diarrhea and fatigue were found to be the most common side effects or side effects of this drug.

These results are interesting and open to exploration. To date, immunotherapy has not been effective in patients with CNS-mCRC tumors. This study demonstrates the potential of the combination of botenlimab and balstilimab in the treatment of CNS mCRC, providing new hope for people diagnosed with colon cancer.

What Could This Mean For Bowel Cancer Treatment In The Future

The study is currently in the final stages of clinical trials, and the US Food and Drug Administration (FDA) hopes to quickly gain approval for its use because of the importance of this area that affects many people. The efficiency shown demonstrates the potential of botansilimab to contribute to broad antitumor immunity.

All in all, the combination of botensilimab and balstilimab represents a promising new direction in the treatment of colorectal cancer. This breakthrough could improve conditions for many patients worldwide and lights a new hope in the fight against this common disease. The results of this study show the effectiveness of immunotherapy in this field and how its potential to transform cancer treatment can only grow in the years to come.

A team of UK scientists has identified 23 unique mutations in the ongoing Ebola outbreak in the Democratic Republic of Congo (DRC) and Uganda, led by the Bundibugyo virus.

The findings, led by scientists from Imperial College London and the University of Oxford, are based on an analysis of 10 available Bundibugyo virus sequences from the Congo and Uganda associated with the current 2026 outbreak, according to Virological.org — an online discussion forum for pathogenic virus sequence data. The forum was launched in November 2014.

The sampled viruses appear to share a most recent common ancestor dating to early-to-mid March 2026, the researchers said.

"The sampled viruses are already genetically diverse. We identified 23 unique mutations across the 10 sequences," said Gina Cuomo-Dannenburg from Imperial College London and Mahan Ghafari from the University of Oxford.

"This level of diversity suggests that the sampled viruses do not represent the very beginning of transmission, but instead reflect an outbreak that had already been circulating, at least partly undetected, for several weeks before sequences became available," they added.

However, the authors noted that "this is an informal analysis and is not intended as a formal preprint or manuscript in its current form" and urged that the estimates "should be interpreted cautiously."

Ebola Cases Continue to Rise

Meanwhile, Congo said on Sunday that the number of confirmed Ebola cases had increased to 515 after 27 new samples tested positive in the previous 24 hours. The confirmed cases include 91 deaths, government data showed.

The Ministry of Health Uganda has confirmed 19 Ebola cases so far, including 14 imported from the DRC and five locally transmitted infections.

According to the World Health Organization, the latest outbreak has resulted in 516 suspected cases and 33 confirmed infections, with as many as 133 deaths reported.

CDC Warns Outbreak Could Rival 2014 Epidemic

The Ebola outbreak spreading through the Democratic Republic of Congo and Uganda could become more devastating than the largest Ebola epidemic in history unless containment efforts improve, according to modelling released by the US CDC.

The models, published in the Morbidity and Mortality Weekly Report, showed that the current outbreak could rival the scale of the 2014 West Africa outbreak, which resulted in more than 28,000 cases and over 11,000 deaths.

"That scale is possible," said Jason Asher, director of the CDC's Center for Forecasting and Outbreak Analytics, during a press briefing.

The worst outcomes could be avoided if "a larger proportion of patients were identified, isolated, and treated," the agency said in its reports.

However, "the public health response to control this outbreak will likely need to be of similar magnitude to the response for the 2014–2016 West Africa Ebola outbreak."

AI-Driven Drug Discovery

There are currently no approved treatments specifically for Bundibugyo ebolavirus, despite the existence of some antiviral therapies for other Ebola species. The rare strain is known to kill up to 40 percent of infected patients.

Scientists at the US' Southwest Research Institute (SwRI) have used AI-driven drug discovery platforms to rapidly identify and synthesize 23 antiviral candidates targeting the Bundibugyo Ebola strain currently affecting Congo.

The newly identified compounds are expected to undergo testing against the Bundibugyo virus in the coming weeks.

Christian Eriksen is a well-known name in the football world and has a huge following. When he collapsed during a friendly match between Denmark and Ukraine, it caused massive concern among the fans of the sport. The Danish Football Federation ensured the fans in a social media post that the veteran player has regained consciousness.

The federation wrote in their X post, “Christian Eriksen ‌is conscious and is doing well under the circumstances.” They also informed that the friendly match between Denmark and Ukraine was called off after this incident.

The football match was well into the 20 minutes of the second half when the incident occurred, and the players from both sides made a circle around the collapsed player. The fans were also in a hush, and medics attended to him on the field. He was eventually able to walk to an ambulance.

Team doctor of Denmark, Morten Boesen, told Danish media, “Christian is doing well and walked from the field himself. As I see it, the pacemaker is working as it should. He was briefly gone, but very quickly regained consciousness, and we were quickly in contact with him.”

Notably, this was not the first time that the midfielder collapsed during a match, as Eriksen suffered cardiac arrest during a European Championship match in Copenhagen in 2021. He was saved by CPR ⁠treatment. Later, he got fitted with a special heart-starting device known as an Implantable Cardioverter-Defibrillator (ICD).

What Is Cardiac Arrest?

Cardiac arrest happens when the heart suddenly stops pumping blood to the body, causing the brain and other organs to be deprived of oxygen. This ceases the function of the heart due to irregular heart rhythms, known as arrhythmias, which prevent the heart from functioning properly. Once the heart stops, blood flow to vital organs halts, leading to unconsciousness, respiratory failure, and, if not treated, can be fatal without treatment.

The condition is commonly referred to as a "silent killer" because it frequently occurs without obvious symptoms. When cardiac arrest happens, there is little time to react, and death can occur within minutes if emergency treatment, such as cardiopulmonary resuscitation (CPR) or defibrillation, is not immediately administered.

Cardiac arrest is a medical emergency, and quick action is essential for survival. The first step in treatment is performing CPR to manually compress the chest and encourage blood flow to the brain and other vital organs. If a defibrillator is available, it can deliver an electric shock to the heart, potentially restoring its normal rhythm.

Also Read: Cholera Outbreak In Nigeria: Death Toll Crosses 39, Cases Exceed 4,200

Why Athletes Are Prone To Cardiac Arrest?

Though heavy running and physical activity are widely believed and proven to be healthy habits, overexertion can cause great harm and can lead to undiagnosed or underlying cardiovascular abnormalities. Though this also depends on the age. Young players often face this problem due to a genetic condition, while older players mostly face it due to acquired coronary disease.

Shigella infection, commonly known as shigellosis, has claimed a 4-year-old's life in Kerala. According to reports from the authorities, three children were admitted to Kozhikode Medical College Hospital with this infection. Though two of them recovered and were discharged, a four-year-old girl, Nila, succumbed to the disease. She was from Thalakkulathur.

After this first fatality due to shigella, the state's health minister K Muraleedharan, addressed a press conference and said that shigella is a bacterial infection that mainly affects the intestines and causes symptoms such as diarrhoea, fever, and abdominal pain.

Muraleedharan said, "The disease mainly spreads through contaminated food and water. Strict hygiene practices are essential to prevent its spread." Then added, "Around 123 cases were reported in Alappuzha and Pathanamthitta districts last week."

The health minister also confirmed that Shigella was not the reason behind gastrointestinal illness among students in Wayanad. Around 164 students from educational institutions in the Sulthan Bathery region reportedly developed symptoms including vomiting and diarrhoea. Initially, there were concerns over them also being infected by Shigella, but preliminary tests showed that they were not infected.

Though he also added that a medical team from Kozhikode Medical College was dispatched to the area, and will collect samples for testing there. He said, "Initial reports suggest that the cases are not related to Shigella, but further testing is underway, and a final report is awaited."

The local authorities have also issued strict instructions on preventive measures. The health department has ordered the food safety department to conduct inspections, and hotels and eateries were instructed to maintain hygiene and ensure the provision of safe drinking water to customers.

The health minister stressed that the local self-government must take proactive measures to ensure public health.

Also Read: Lung Cancer Risk May Be Detected With Blood Marker 5 Years In Advance, Australian Study Finds

What Is Shigella?

Shigella is a highly infectious bacterium that causes gastrointestinal illness, commonly known as shigellosis. Its symptoms often include diarrhea, fever, and stomach cramps, which can range from mild to severe. Estimates suggest around 188 million cases occur each year, leading to over 1.6 lakh deaths due to Shigella throughout the world.

The infection spreads easily through contact with contaminated food, water, or surfaces, and through person-to-person transmission. Though it is a very infectious bacterium, certain groups are more vulnerable to infection. These groups include young children and people with weakened immunity. Notably, exposure risk increases in environments where hygiene practices may vary.

How To Prevent Shigellosis?

Early recognition and treatment with appropriate antibiotics is crucial to protect oneself from this disease. Notably, ORS can help prevent dehydration, while Zinc tablets can enhance recovery. Other measures to prevent the spread include washing hands with soap and water, especially before touching food, and after using the toilet, and maintaining hygiene. Controlling flies is also very important to prevent the disease.